Clinical Trials for Neowise Biotechnology

Explore 3 clinical trials worldwide

Showing 1-3 of 3 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Neowise Biotechnology

Clinical Trials (3)

NCT06484556
T Cell Receptor Gene-Engineered T Cell Therapy Targeting KRAS Mutations in the Treatment of Subjects With Advanced Solid Tumor
PHASE1Recruiting
9 participants
Started: Jun 19, 2024 · Completed: Jun 30, 2027
1 condition2 sponsors2 locations
NCT06484790
T Cell Receptor Gene-Engineered T Cell Therapy Targeting KRAS Mutations in the Treatment of Subjects With Advanced Solid Tumor
PHASE1Recruiting
9 participants
Started: Apr 8, 2024 · Completed: Apr 7, 2027
1 condition2 sponsors1 location
NCT06478251
T Cell Receptor Gene-Engineered T Cell Therapy Targeting KRAS Mutations in the Treatment of Subjects With Advanced Solid Tumor
PHASE1Recruiting
9 participants
Started: Feb 1, 2024 · Completed: Jun 30, 2027
1 condition2 sponsors1 location